中旗股份(300575.SZ)：公司氯虫苯甲酰胺预计今年四季度投产并逐步供应市场

Core Viewpoint - The company is progressing towards the production of chlorantraniliprole, with expectations to commence production in the fourth quarter of this year [1] Group 1 - The company is accelerating the various stages required for the trial production to formal production of chlorantraniliprole [1] - The company is actively applying for necessary permits and procedures related to the production [1] - The production of chlorantraniliprole is being advanced in an orderly manner [1] Group 2 - The company has noted discussions in media and online platforms regarding the supply chain related to chlorantraniliprole [1] - In a previous announcement, the company indicated that industry-related incidents and the production of chlorantraniliprole at its Guorui factory would have a limited impact on the company [1] - The company has repeatedly urged investors to be aware of investment risks and to make rational decisions [1]